Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia (RAPIDS-GN)

NCT03218397 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03218397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03218397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia (RAPIDS-GN)
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Completed
Start date
October 9, 2017
Completion date
November 30, 2018
Enrollment
500 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gram-negative bacteremia